ISSN: 0973-7510

E-ISSN: 2581-690X

Dudi Hardianto1,2, Marlia Singgih Wibowo1, Amir Musadad1, Wahono Sumaryono2, Juwartina Ida Royani2, and Tutus Gusdinar1
1School of Pharmacy Technology Institute of Bandung, Indonesia.
2Biotech Center, The Agency for the Assessment and Application of Technology, Indonesia.
J Pure Appl Microbiol. 2012;6(2):609-613
© The Author(s). 2012
Received: 20/01/2012 | Accepted: 27/02/2012 | Published: 30/06/2012
Abstract

Protoplasts  of A. terreus were transformed by pTRLI plasmid containing lovE gene as regulator gene in lovastatin biosynthesis and ptrA gene as pyritiamine resistance gene. Transformats were selected for ability to grow on Czapex-dox agar containing pyrithiamine. Transformats were stable and grew on Czapex-dox agar containing pyrithiamine for 5 generations.  A. terreus transformant is tested for lovastatin productivity using medium fermentation. This research showed that copy number of lovE gene in A. terreus increased significantly lovastatin productivity. The lovastatin productivity of A. terreus recombinant was 693 ppm, which is 93% hingher than the parental strain (398 ppm) at 28oC for 7 days and 200 rpm.

Keywords

Lovastatin, Aspergillus terreus recombinant, Transformation, pTRLI plasmid

Article Metrics

Article View: 682

Share This Article

© The Author(s) 2012. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.